VKH
AST.WS

Virtu KCG Holdings’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Virtu KCG Holdings’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$12K Buy
+23,007
New +$10.4K ﹤0.01% 2771

Other funds holding AST.WS

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Virtu KCG Holdings's AST.WS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q2 2017: 23,007 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2771 among its holdings.

33 funds tracked by Wall St. Rank hold AST.WS as of Q2 2017.

  • Virtu KCG Holdings held 23,007 shares of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) worth $12K as of Q2 2017.
  • Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) was a new Virtu KCG Holdings position in Q2 2017.
  • Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2771 holding.
  • 33 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.